• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Aragon Pharmaceuticals

edit

Aragon Pharmaceuticals is a discovery-stage small molecule company focused on therapeutics for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer.

Recent Milestones

edit

• 
  Aragon Pharmaceuticals was acquired by Johnson & Johnson for $1B. (6/17/13)
  Posted 6/17/13 at 8:06pm via firstwordpharma.com
• 
  Aragon Pharmaceuticals received $50M in Series D funding. (10/4/12)
  Posted 10/5/12 at 2:10am via prnewswire.com
• 
  Aragon Pharmaceuticals received $42M in Series C funding. (3/6/12)
  Posted 3/6/12 at 5:15am via xconomy.com
• 
  Aragon Pharmaceuticals received $22M in Series B funding. (4/22/10)
  Posted 4/22/10 at 9:31am via fiercebiotech.com
• 
  Aragon Pharmaceuticals received $8M in Series A funding. (5/27/09)
  Posted 6/17/09 at 1:23pm via onbiovc.com
• 
  Aragon Pharmaceuticals added Angie You as Chief Business Officer.
  Posted 6/9/13 at 9:34am
• 
  Aragon Pharmaceuticals added Carl Gordon as Board of Director.
  Posted 6/9/13 at 9:34am
• 
  Aragon Pharmaceuticals added Peter Svennilson as Board of Director.
  Posted 6/9/13 at 9:34am
• 
  Aragon Pharmaceuticals added Brett Zbar as Board of Director.
  Posted 6/9/13 at 9:34am
• 
  Aragon Pharmaceuticals added Paul Cleveland as Executive Vice President of Corporate Strategy Chief Financial Officer.
  Posted 6/9/13 at 9:34am
• 
  Aragon Pharmaceuticals added Isan Chen as Chief Medical Officer.
  Posted 3/6/12 at 5:24am
• 
  Aragon Pharmaceuticals added Richard Heyman as President and Chief Executive Officer.
  Posted 3/6/12 at 5:24am
• 
  Aragon Pharmaceuticals added Carol Gallagher as Board of Director.
  Posted 6/9/13 at 9:34am
• 
  Aragon Pharmaceuticals added Charles Sawyers as Scientific Advisor.
  Posted 6/9/13 at 9:34am
• 
  Aragon Pharmaceuticals added José Baselga as Scientific Advisor.
  Posted 6/9/13 at 9:34am
• 
  Aragon Pharmaceuticals added Ronald M. Evans as Scientific Advisor.
  Posted 6/9/13 at 9:34am

Videos

Screenshots

edit

Above: Aragon Pharmaceuticals
Uploaded: 3/6/12

Sources

1. Johnson & Johnson boosts cancer drug pipeline with $1-billion deal to buy Aragon Pharmaceuticals (firstwordpharma.com) [edit]
2. Aragon Pharmaceuticals, Inc.: Series A $8M (onbiovc.com) [edit]
3. Aragon Pharma readies first cancer trial after $22M B round (fiercebiotech.com) [edit]
4. San Diego’s Aragon Raises $42 Million, Targets Hormone-Driven Cancers (xconomy.com) [edit]
5. Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers (prnewswire.com) [edit]